Norway Osteoarthritis Injectables Market Size & Outlook
Norway osteoarthritis injectables market, 2018-2030 (US$M)
Related Markets
Norway osteoarthritis injectables market highlights
- The Norway osteoarthritis injectables market generated a revenue of USD 44.9 million in 2023 and is expected to reach USD 67.9 million by 2030.
- The Norway market is expected to grow at a CAGR of 6.1% from 2024 to 2030.
- In terms of segment, hyaluronic acid injections was the largest revenue generating injection type in 2023.
- Hyaluronic Acid Injections is the most lucrative injection type segment registering the fastest growth during the forecast period.
Osteoarthritis injectables market data book summary
| Market revenue in 2023 | USD 44.9 million |
| Market revenue in 2030 | USD 67.9 million |
| Growth rate | 6.1% (CAGR from 2023 to 2030) |
| Largest segment | Hyaluronic acid injections |
| Fastest growing segment | Hyaluronic Acid Injections |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Corticosteroid Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Acetylsalicylic Acid (ASA) Injections |
| Key market players worldwide | Anika Therapeutics Inc, Bioventus Inc Class A, Ferring, Sanofi SA, Zimmer Biomet Holdings Inc, Arthrex, Pacira BioSciences Inc, Royal Biologics, Teva Pharmaceutical Industries Ltd |
Other key industry trends
- In terms of revenue, Norway accounted for 0.6% of the global osteoarthritis injectables market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany osteoarthritis injectables market is projected to lead the regional market in terms of revenue in 2030.
- Denmark is the fastest growing regional market in Europe and is projected to reach USD 42.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Osteoarthritis Injectables Market Scope
Osteoarthritis Injectables Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Norway osteoarthritis injectables market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to osteoarthritis injectables market will help companies and investors design strategic landscapes.
Hyaluronic acid injections was the largest segment with a revenue share of 38.75% in 2023. Horizon Databook has segmented the Norway osteoarthritis injectables market based on corticosteroid injections, hyaluronic acid injections, platelet-rich plasma (prp) injections, placental tissue matrix (ptm) injections, acetylsalicylic acid (asa) injections covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Norway osteoarthritis injectables market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Norway osteoarthritis injectables market databook
-
Our clientele includes a mix of osteoarthritis injectables market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway osteoarthritis injectables market , including forecasts for subscribers. This country databook contains high-level insights into Norway osteoarthritis injectables market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Norway osteoarthritis injectables market size, by injection type, 2018-2030 (US$M)
Norway Osteoarthritis Injectables Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
